BioAtla (BCAB) Stock Forecast & Price Prediction

Estimation of the future price movement of BioAtla stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $2.85

Concensus $0.00


Low $0.00

Median $0.00

High $0.00

Based on analysts projections #BCAB is expected to experience a price decline over the next year.

The current average BCAB price target, as estimated by these analysts, is $0.00.

The predictions for the future BCAB stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BCAB.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

BCAB stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted

There are no data to display

BioAtla (BCAB) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if BioAtla is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 03/03/2024

Altman Z-Score: -4.2

Piotroski Score: 2.0

ESG Score

Updated on: 03/03/2024

Environmental: 56.5

Social: 57.0

Governance: 57.4

Financial Health

Updated on: 03/03/2024

DCF: Strong Buy

ROE: Strong Sell

ROA: Sell

Debt to equity ratio: Neutral

Price to earnings ratio: Sell

Price to book ratio: Buy

BCAB Discounted Cash Flow

Updated on: 03/03/2024

$0.000
Discounted Cash Flow Value


$0.000
Current Price

BCAB Revenues by Segment

Updated on: 03/03/2024

No available data

Revenue from Contract with Customer, Excluding Assessed Tax

BCAB Revenues by Region

Updated on: 03/03/2024

No available data

BCAB Notes Due

Updated on: 03/03/2024

CIKExchangeTitle

There are no data to display

BioAtla (BCAB) Social Sentiments

Monitoring bullish and bearish sentiments towards BioAtla on Twitter and Stocktwits could help to forecast an upward or downward trend in BioAtla stock price.

BioAtla's Promising Pipeline and Bullish Stock Forecast: A Look into the Future of Biotech

BioAtla, a California-based biotechnology company, with stock ticker BCAB, is making waves in the biotech industry with its innovative and cutting-edge antibody technology. Founded in 2007, BioAtla is focused on developing antibody therapeutics for the treatment of cancer and other diseases. BioAtla's proprietary technology platform is based on a novel approach to engineering antibodies that enables the selective targeting of... Read more

BioAtla: A Rising Biotech Star with Promising Stock Prediction

The Biotechnology sector is a fascinating area of the stock market that has become increasingly popular among investors in recent years. Biotechnology companies are primarily focused on developing new and innovative treatments for various diseases and medical conditions by manipulating living organisms. One such company making waves in the biotech industry is BioAtla, affectionately known with the ticker symbol BTA.... Read more